Arthritis News and Research

Latest Arthritis News and Research

Study comparing the efficacy of REMICADE® to Azathioprine alone and in combination With REMICADE®

Centocor, Inc., and Schering-Plough Corporation announced today the initiation of the SONIC (Study of Immunomodulator Naive patients in Crohn's Disease) trial that will evaluate the efficacy of REMICADE® (infliximab) versus azathioprine, a conventional immunosuppressive agent, alone and versus the combination of both drugs for the treatment of patients with Crohn's disease.

18 May 2004

First filing for zoledronic acid in metabolic bone disease

One 15-minute infusion of the intravenous bisphosphonate zolendronic acid more rapidly reduced the biochemical markers of bone turnover in patients with Paget's disease than was seen in a head-to-head comparison with the oral treatment risedronate (95% vs. 75% response rate).

17 May 2004

Facts about prevalence of arthritis in the U.S.A

Arthritis is the leading cause of physical disability in the United States. Arthritis comprises over 100 different disease and conditions. The most common are osteoarthritis, rheumatoid arthritis, fibromyalgia, and gout.

15 May 2004

Study of hematopoietic stem cell transplantation for severe, treatment-resistant lupus

The study will include a basic research component to examine the roles of B and T cells, white blood cells in the immune system, in triggering lupus symptoms.

14 May 2004

Study to Look at effect of exercise and education on osteoarthritis

Researchers at the Arizona Arthritis Center at the University of Arizona College of Medicine are investigating the effect of early interventions in the treatment of osteoarthritis, a condition currently affecting tens of thousands of Tucsonans.

12 May 2004

Scottish health professionals tackle problems of obesity

The University of Glasgow is bringing together experts in the field of obesity management to address a conference on Friday 7 May 2004 for health professionals on how to tackle obesity.

6 May 2004

The First International Congress on Antioxidant Methods

The First International Congress on Antioxidant Methods will be held June 16-18 in Orlando, Fla., in an effort to reach agreement on techniques for measuring and reporting on antioxidants, beneficial compounds found in foods, cosmetics and certain vitamins that are believed to fight cancer, heart disease and aging.

6 May 2004

Weight loss and exercise regime helps osteoarthritis

A combination of moderate weight loss and exercise is an effective treatment for overweight adults with osteoarthritis of the knee, according to new research from Wake Forest University published in the May issue of the journal Arthritis & Rheumatism.

6 May 2004

Organic superglues, disease treatments and better food flavourings

Organic superglues, disease treatments and better food flavourings: these are some of the projects where synthetic organic chemist Carol Taylor employs her skills.

5 May 2004

Immtech signs agreement with CombinatoRx to test Immtech compounds as potential cancer treatment

Immtech International, Inc. announced today that it signed an agreement with CombinatoRx of Boston, Massachusetts to screen its lead aromatic cationic compounds, DB289 and DB75, for activity against various cancers.

5 May 2004

Study identifies key factor causing low iron and anemia in patients with infections and major inflammatory diseases

UCLA researchers found that a member of the immune system’s defense team stimulates a chain reaction leading to chronic anemia in many patients with infections and major inflammatory diseases.

3 May 2004

New medicare website shows inaccurate pricing

The new Medicare Web site with comparative prescription drug pricing contains inaccurate, erroneous information, sponsors of drug discount cards said on Friday. Companies offering the cards said the government and its contractor had posted inaccurate data just hours after the web site launch.

1 May 2004

$9 billion cost of depression in senior citizens

A new study reveals that depression among senior citizens carries a huge unrecognized cost: many extra hours of unpaid help with everyday activities, delivered by the depressed seniors’ spouses, adult children and friends.

1 May 2004

FDA approves new drug Enbrel for psoriasis

The U.S. Food and Drug Administration has approved the biologic drug etanercept (brand name Enbrel) to treat chronic, moderate to severe plaque psoriasis in adults.

1 May 2004

Psoriasis medications can treat more than the skin

The National Psoriasis Foundation, Dermatology Nurses Association, Dermatologists and People with Psoriasis have collaborated to offer a new resource to help people with psoriasis cope with the social and emotional impact of psoriasis.

27 Apr 2004

A new study is better defining the impact that stress and depression have on women suffering from rheumatoid arthritis

A new study is better defining the impact that stress and depression have on women suffering from rheumatoid arthritis (RA). The research, led by a team of ASU psychologists, shows increased pain and inflammation for those dealing with high amounts of stress and depression.

26 Apr 2004

Diets like Atkins could help prevent Alzheimer's, cancer, diabetes and Parkinson's disease

Though diets like Atkins and South Beach are the current rage, an emerging eating philosophy may do more than temporarily take off pounds: It could help treat disease.

26 Apr 2004

Protein may help prevent autoimmune conditions like diabetes, lupus, arthritis and multiple sclerosis

A possibly important ally of the immune system that can help with the tricky task of separating friend from foe has been identified by scientists at Washington University School of Medicine in St. Louis.

23 Apr 2004

Helping doctors to prescribe the right medication

With so many new drugs on the market to treat arthritis and related disorders, how do doctors know which ones to use?

23 Apr 2004

CellCept linked to reduced cancer incidence

A study presented today at an international transplant meeting showed that heart transplant patients treated with the immunosuppressant CellCeptÒ (mycophenolate mofetil) in standard immunosuppressive regimens had a significantly lower risk of developing cancer compared to those receiving non-CellCept-based treatment regimens.

23 Apr 2004

Arthritis News and Research

Latest Arthritis News and Research

Study comparing the efficacy of REMICADE® to Azathioprine alone and in combination With REMICADE®

First filing for zoledronic acid in metabolic bone disease

Facts about prevalence of arthritis in the U.S.A

Study of hematopoietic stem cell transplantation for severe, treatment-resistant lupus

Study to Look at effect of exercise and education on osteoarthritis

Scottish health professionals tackle problems of obesity

The First International Congress on Antioxidant Methods

Weight loss and exercise regime helps osteoarthritis

Organic superglues, disease treatments and better food flavourings

Immtech signs agreement with CombinatoRx to test Immtech compounds as potential cancer treatment

Study identifies key factor causing low iron and anemia in patients with infections and major inflammatory diseases

New medicare website shows inaccurate pricing

$9 billion cost of depression in senior citizens

FDA approves new drug Enbrel for psoriasis

Psoriasis medications can treat more than the skin

A new study is better defining the impact that stress and depression have on women suffering from rheumatoid arthritis

Diets like Atkins could help prevent Alzheimer's, cancer, diabetes and Parkinson's disease

Protein may help prevent autoimmune conditions like diabetes, lupus, arthritis and multiple sclerosis

Helping doctors to prescribe the right medication

CellCept linked to reduced cancer incidence

Delayed immune responses may be responsible for COVID-19 mortality rates

Are micro and nanoplastics accumulating in human organs and tissues?

A potential new way of treating Alzheimer’s Disease

Arthritis News and Research

Latest Arthritis News and Research

Newsletters you may be interested in